… release from the company. Merck Looks to Expand Keytruda … Into Ovarian Cancer Merck is seeking to add … To support its application, Merck submitted data from the Phase … tremors and intellectual disabilities. Sanofi, Regeneron Eye Another Indication …

… CNPV program. The awardees include Sanofi’s type 1 diabetes drug … was considering granting two to Merck—even though the companies had …

… . Top Companies in Pharmaceuticals Market Merck & Co., Inc. (U.S … Lilly and Company (U.S.) Sanofi (France) Novo Nordisk A…

… Merck & Co., Rahway, NJ, Pfizer, Pfizer/Myovant, Sanofi … , Seagen, and the healthcare business of Merck KGaA, … and the healthcare business of Merck KGaA, Darmstadt, Germany; … and the healthcare business of Merck KGaA, Darmstadt, Germany. …

… Active Pharmaceutical Ingredients Reserve.11 Merck As part of their agreement … with the Trump Administration, Merck will provide key products from … while strengthening innovation. News Release. Sanofi. Released December 19, 2025. Accessed …

… Bioscience, Rome Pharmaceuticals, Horizon, Gilead, Merck, Kezar, Sanofi, Bayer, Akari, Calyx, Cabaletta …

… solutions against Gram-negative bacteria. Sanofi acquired Vicebio in December 2025 … and participation in subscription models; Merck & Co Inc., focusing on … GSK, AstraZeneca plc, AbbVie Inc., Sanofi S.A., Abbott, BASF SE …

… Dodds, Clinical Trials Startup Lead, Sanofi Shanny Dyer, Director, Rheumagen Australia … Umesh Nair, Major Account Manager, Merck Life Science Jasmine Oberwalleney, APAC …

… . Nirsevimab (Beyfortus, Sanofi and AstraZeneca) and clesrovimab (Enflonsia, Merck) provide about 5 …

… obesity-focused Metsera, and Merck’s $10 billion purchase … Near-$10 billion deals included Sanofi’s $9.5 billion … cardiovascular disease, followed by Merck with three acquisitions and Johnson … Abbott, AstraZeneca, GSK, and Merck KGaA, each completed a single …